Detalles de la búsqueda
1.
Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial.
Eur J Nucl Med Mol Imaging
; 50(2): 572-580, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127416
2.
High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results.
Eur J Nucl Med Mol Imaging
; 48(5): 1511-1521, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140131
3.
Theragnostics in prostate cancer.
Q J Nucl Med Mol Imaging
; 65(4): 333-341, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35133097
4.
Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer.
Eur J Nucl Med Mol Imaging
; 47(1): 136-146, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31492993
5.
Predictive accuracy and clinical benefit of a nomogram aimed to predict 68Ga-PSMA PET/CT positivity in patients with prostate cancer recurrence and PSA < 1 ng/ml external validation on a single institution database.
Eur J Nucl Med Mol Imaging
; 47(9): 2100-2105, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32006061
6.
Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancer.
Curr Opin Urol
; 30(5): 641-648, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32701717
7.
Theragnostic: radiopharmaceuticals and nuclear medicine as viewed through Hegel's eyes.
Eur J Nucl Med Mol Imaging
; 51(4): 942-946, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38114617
8.
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.
Eur J Nucl Med Mol Imaging
; 46(1): 31-39, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350010
9.
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.
Eur J Nucl Med Mol Imaging
; 46(1): 11-19, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905907
10.
Case of the month from the Radiotherapy Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy: breaking boundaries beyond five lesions with multifocal stereotactic radiotherapy in prostate cancer.
BJU Int
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38775027
11.
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
World J Urol
; 37(12): 2607-2613, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29752513
12.
Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
Q J Nucl Med Mol Imaging
; 63(1): 7-18, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29521482
13.
How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?
Int J Urol
; 26(8): 804-811, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31083784
14.
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.
Int J Urol
; 26(1): 18-30, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30238516
15.
Successful treatment of a chemotherapy-resistant t(17;19) paediatric ALL with a combination of inotuzumab, venetoclax and navitoclax.
Br J Haematol
; 202(5): e39-e42, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37350036
16.
Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature.
BMC Cancer
; 18(1): 7, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29295713
17.
New aspects of molecular imaging in prostate cancer.
Methods
; 130: 36-41, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28711565
18.
Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Int J Gynecol Cancer
; 28(3): 575-580, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29372911
19.
Therapy assessment in prostate cancer using choline and PSMA PET/CT.
Eur J Nucl Med Mol Imaging
; 44(Suppl 1): 78-83, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28540419
20.
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence.
Eur J Nucl Med Mol Imaging
; 44(10): 1712-1720, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28405727